P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial

M. Pérol, M.-J. Ahn, Yun Cheng, Jennifer Clarke, A.-M. Dingemans, Caryl Gay, A. Navarro, M. Schuler, Takeshi Yoshida, Pablo Martínez,

Journal of Thoracic Oncology · 2024 · 11 citations · 0 references

DOIFull text

Open access

Concepts